Amgen :
AMGN
AMGN
Stock Data
$332.64
$7.52 (2.21%)
Asset Type
Common Stock
Exchange
NASDAQ
Currency
USD
Country
USA
Sector
HEALTHCARE
Industry
DRUG MANUFACTURERS - GENERAL
Amgen Inc. is a biotechnology pioneer focused on developing and delivering innovative human therapeutics. Its portfolio includes treatments for serious illnesses such as rheumatoid arthritis, psoriasis, osteoporosis, and various types of cancer. Among its well-known products are Enbrel, Otezla, Prolia, and Repatha. Amgen also collaborates with other pharmaceutical giants to enhance its product offerings, demonstrating a commitment to improving patient health globally. Founded in 1980, Amgen has grown to serve healthcare providers and patients worldwide from its headquarters in Thousand Oaks, California.
All Amgen Articles
691 Articles